Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.

about

Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.

Item

http://www.wikidata.org/entity/Q47414662

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@en

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@nl

type

Item

label

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@en

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@nl

prefLabel

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@en

Betaine enhances antidepressan ...... c effects of ketamine in mice.

@nl

P1476

Betaine enhances antidepressan ...... ic effects of ketamine in mice

@en

P2093

Hwei-Hsien Chen

http://www.w3.org/2001/XMLSchema#string

Jen-Cheng Lin

http://www.w3.org/2001/XMLSchema#string

Mei-Yi Lee

http://www.w3.org/2001/XMLSchema#string

Yi-Chyan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats

HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine.

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

P2888

s00213-016-4359-x

P304

3223-3235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-016-4359-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Ming-Huan Chan

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27363702

http://www.w3.org/2001/XMLSchema#string